SEC Form 8-K filed by Sylvamo Corporation

SEC Form 8-K filed by Sylvamo Corporation

SEC Form 8-K filed by Sylvamo Corporation

SEC Form 8-K filed by Sylvamo Corporation

Recent Analyst Ratings for
$SLVM

Recent Analyst Ratings for
$SLVM

$SLVM
SEC Filings

Crush Q3 2025 with the Best AI Executive Assistant

Crush Q3 2025 with the Best AI Executive Assistant

SEC Form 144 filed by Sylvamo Corporation

5/16/25 2:03:41 PM ET

$SLVM

Paper

Basic Materials

Get the next $SLVM alert in real time by email

8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 15, 2025

SYLVAMO CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

001-40718

86-2596371

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)


6077 Primacy Parkway, Memphis, Tennessee		38119
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (901) 519-8000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, $1 per share par value

SLVM

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On May 15, 2025, the Board of Directors (the “Board”) of Sylvamo Corporation (the “Company”) adopted and approved, effective immediately, the second amended and restated By-Laws of the Company (as amended and restated, the “Second Amended and Restated By-Laws”). The Second Amended and Restated By-Laws, among other things:

•

revise and clarify the scope of certain procedures and disclosure requirements set forth in the by-law provisions for stockholders to provide advance notice of director nominations and business proposals to be brought at a meeting of stockholders (other than proposals submitted pursuant to Rule 14a-8 under the Exchange Act);

•

revise the majority voting provision to clarify when an election will be deemed contested;

•

specify that the Board may propose business at a special meeting of stockholders requested by one or more stockholders; and

•

make certain administrative, modernizing, clarifying and conforming changes, including making updates to reflect recent amendments to the General Corporation Law of the State of Delaware.

The foregoing summary of the Second Amended and Restated By-Laws does not purport to be complete and is qualified in its entirety by reference to the full text of the Second Amended and Restated By-Laws, which is attached as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 5.07.

Submission of Matters to a Vote of Security Holders.

(a)

The Company held its annual meeting of stockholders on May 15, 2025.

(b)

Of the 40,720,315 shares outstanding on the record date and entitled to vote at the meeting, 37,932,359 shares were present at the meeting in person or by proxy, constituting a quorum of ninety-three percent (93%). The stockholders of the Company’s common stock considered and voted at the meeting upon the three Company proposals listed below. This report discloses the final voting results for the meeting.

Proposal 1 – Elect ten director nominees to the Company’s board of directors

The Company’s stockholders elected each of the individuals listed below as directors to serve until the next annual meeting of the Company and until their successors have been duly elected and qualified, or their earlier resignation.


Directors	For		Against		Abstain		Broker Non-Votes
Jean-Michel Ribiéras		31,986,180		1,517,458		20,822		4,407,898
Stan Askren		33,437,431		66,163		20,866		4,407,898
Christine S. Breves		33,462,982		41,067		20,411		4,407,898
Lizanne M. Bruce		33,214,760		289,248		20,452		4,407,898
Jeanmarie Desmond		33,221,298		274,682		28,480		4,407,898
Joia M. Johnson		33,164,767		330,856		28,837		4,407,898
Karl L. Meyers		33,129,491		298,548		96,421		4,407,898
David Petratis		33,186,203		317,361		20,896		4,407,898
Mark W. Wilde		33,245,648		257,991		20,821		4,407,898
James P. Zallie		33,471,664		31,774		21,022		4,407,898

Proposal 2 – Ratify the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm

The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.


For	Against	Abstain	Broker Non-Votes
37,845,026	66,493	20,839	—

Proposal 3 – Approve on a non-binding advisory basis the compensation of the Company’s named executive officers (“NEOs”)

The Company’s stockholders approved the compensation of the Company’s NEOs on a non-binding advisory basis.


For	Against	Abstain	Broker Non-Votes
31,766,811	1,668,194	89,455	4,407,898

Item 9.01

Financial Statements and Exhibits.


Exhibit Number		Description

3.1		Second Amended and Restated By-Laws

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Get the next $SLVM alert in real time by email

Recent Analyst Ratings for

$SLVM

Date	Price Target	Rating	Analyst
12/11/2024	$96.00	Neutral → Underperform	BofA Securities
10/15/2024	$100.00	Buy	Sidoti
8/12/2024	$71.00 → $82.00	Buy → Neutral	BofA Securities
8/10/2023	$55.00 → $44.00	Outperform → Sector Perform	RBC Capital Mkts
7/10/2023	$52.00 → $61.00	Neutral → Buy	BofA Securities
12/15/2022	$56.00 → $58.00	Buy → Neutral	BofA Securities
10/13/2022	$56.00	Buy	BofA Securities
4/7/2022	$40.00 → $43.00	Sector Perform → Outperform	RBC Capital Mkts

More analyst ratings

5/16/25 2:03:41 PM ET

$SLVM

Paper

Basic Materials

Get the next $SLVM alert in real time by email

8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 15, 2025

SYLVAMO CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

001-40718

86-2596371

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)


6077 Primacy Parkway, Memphis, Tennessee		38119
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (901) 519-8000

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, $1 per share par value

SLVM

New York Stock Exchange

Emerging growth company ☐

Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

•

revise the majority voting provision to clarify when an election will be deemed contested;

•

specify that the Board may propose business at a special meeting of stockholders requested by one or more stockholders; and

•

make certain administrative, modernizing, clarifying and conforming changes, including making updates to reflect recent amendments to the General Corporation Law of the State of Delaware.

Item 5.07.

Submission of Matters to a Vote of Security Holders.

(a)

The Company held its annual meeting of stockholders on May 15, 2025.

(b)

Proposal 1 – Elect ten director nominees to the Company’s board of directors


Directors	For		Against		Abstain		Broker Non-Votes
Jean-Michel Ribiéras		31,986,180		1,517,458		20,822		4,407,898
Stan Askren		33,437,431		66,163		20,866		4,407,898
Christine S. Breves		33,462,982		41,067		20,411		4,407,898
Lizanne M. Bruce		33,214,760		289,248		20,452		4,407,898
Jeanmarie Desmond		33,221,298		274,682		28,480		4,407,898
Joia M. Johnson		33,164,767		330,856		28,837		4,407,898
Karl L. Meyers		33,129,491		298,548		96,421		4,407,898
David Petratis		33,186,203		317,361		20,896		4,407,898
Mark W. Wilde		33,245,648		257,991		20,821		4,407,898
James P. Zallie		33,471,664		31,774		21,022		4,407,898

Proposal 2 – Ratify the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm

The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.


For	Against	Abstain	Broker Non-Votes
37,845,026	66,493	20,839	—

Proposal 3 – Approve on a non-binding advisory basis the compensation of the Company’s named executive officers (“NEOs”)

The Company’s stockholders approved the compensation of the Company’s NEOs on a non-binding advisory basis.


For	Against	Abstain	Broker Non-Votes
31,766,811	1,668,194	89,455	4,407,898

Item 9.01

Financial Statements and Exhibits.


Exhibit Number		Description

3.1		Second Amended and Restated By-Laws

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Get the next $SLVM alert in real time by email

Recent Analyst Ratings for

$SLVM

Date	Price Target	Rating	Analyst
12/11/2024	$96.00	Neutral → Underperform	BofA Securities
10/15/2024	$100.00	Buy	Sidoti
8/12/2024	$71.00 → $82.00	Buy → Neutral	BofA Securities
8/10/2023	$55.00 → $44.00	Outperform → Sector Perform	RBC Capital Mkts
7/10/2023	$52.00 → $61.00	Neutral → Buy	BofA Securities
12/15/2022	$56.00 → $58.00	Buy → Neutral	BofA Securities
10/13/2022	$56.00	Buy	BofA Securities
4/7/2022	$40.00 → $43.00	Sector Perform → Outperform	RBC Capital Mkts

More analyst ratings

Date: May 16, 2025

Sylvamo Corporation

/s/ Matthew Barron

Matthew Barron

Senior Vice President and Chief Administrative
and Legal Officer